Wcm Investment Management, LLC Fibrogen Inc Transaction History

Wcm Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$23.3 - $45.96 $901,779 - $1.78 Million	-38,703 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$34.58 - $48.06 $1.03 Million - $1.43 Million	29,697 Added 329.75%	38,703 $1.66 Million
Q2 2019 Aug 06, 2019	SELL	$35.13 - $55.53 $4,918 - $7,774	-140 Reduced 1.53%	9,006 $407,000
Q1 2019 May 13, 2019	BUY	$42.83 - $59.91 $391,723 - $547,936	9,146 New	9,146 $497,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wcm Investment Management, LLC with notifications on news.